nus synthetic biology for clinical and technological innovation

7 Must-Read Stories In November 2017

Outstanding scientists, ambitious biotech startups, modernized acupuncture and a video of CRISPR in action were the hottest topics of November 2017.

Asia’s Rising Scientists: Matthew Chang

Associate Professor Matthew Chang is leading a team of interdisciplinary scientists to reprogram living organisms to perform useful functions for humans.

7 Must-Read Stories In October 2015

From driverless cars to liquid microfluidics sensors, research from Singapore is heavily featured in our top articles published in October 2015.

NUS Launches US$18 Million Program In Synthetic Biology

The NUS Synthetic Biology for Clinical and Technological Innovation (SynCTI) hopes to position Singapore as one of the leading synthetic biology hubs of the world.